Powered by its proprietary Yuvee UV-C Technology, Germitec is shifting the approach to high-level disinfection (HLD) in ultrasound, replacing traditional chemical-based processes with a fast, automated, traceable, and sustainable workflow. A leading innovator in infection prevention, Germitec developed Chronos, the first UV-C ultrasound probe HLD system to receive FDA De Novo classification in the United States. Designed for compatible endocavitary and external ultrasound probes, Chronos uses a three-step process: load, disinfect and trace.
The patented Yuvee UV-C platform delivers validated disinfection in approximately 90 seconds. A reflective chamber supports exposure across compatible probe surfaces, while internal photodiodes monitor the delivered dose and provide an independent second verification before cycle approval. GermiTrac automatically captures documentation and traceability records to support consistency, compliance and audit readiness. The result is faster probe availability, simplified training, repeatability and improved workflow efficiency for imaging and sterile processing teams.
Validated to AOAC and ASTM HLD standards, Chronos is proven effective against HPV-16, HPV-18, HIV, bacteria, fungi, mycobacteria, and spores, giving healthcare organizations a fast, compliant path to modern probe disinfection. By combining automated HLD, cycle verification, traceability, and chemical-free operation, Germitec helps healthcare organizations address clinical, operational, financial, and sustainability priorities through one standardized process.
